These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 17492904)
1. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis. Neuhaus O; Hartung HP Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904 [TBL] [Abstract][Full Text] [Related]
2. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate. Neuhaus O; Stüve O; Archelos JJ; Hartung HP J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504 [TBL] [Abstract][Full Text] [Related]
3. Toward a role for statins in immunomodulation. Mach F Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398 [TBL] [Abstract][Full Text] [Related]
4. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218 [TBL] [Abstract][Full Text] [Related]
5. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294 [TBL] [Abstract][Full Text] [Related]
6. Effects of statins on biomarkers of bone metabolism: a randomised trial. Stein EA; Farnier M; Waldstreicher J; Mercuri M; Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):84-7. PubMed ID: 11434192 [TBL] [Abstract][Full Text] [Related]
7. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594 [TBL] [Abstract][Full Text] [Related]
8. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Zhou Z; Rahme E; Pilote L Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles. Neuhaus O; Stüve O; Zamvil SS; Hartung HP CNS Drugs; 2005; 19(10):833-41. PubMed ID: 16185093 [TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257 [TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study). Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR; Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315 [TBL] [Abstract][Full Text] [Related]
14. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027 [TBL] [Abstract][Full Text] [Related]
15. The potential role for statins in the treatment of multiple sclerosis. Darlington CL Curr Opin Investig Drugs; 2005 Jul; 6(7):667-71. PubMed ID: 16044661 [TBL] [Abstract][Full Text] [Related]
16. Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction. Strandberg TE; Holme I; Faergeman O; Kastelein JJ; Lindahl C; Larsen ML; Olsson AG; Pedersen TR; Tikkanen MJ; Am J Cardiol; 2009 May; 103(10):1381-5. PubMed ID: 19427432 [TBL] [Abstract][Full Text] [Related]
17. Are statins a treatment option for multiple sclerosis? Neuhaus O; Stüve O; Zamvil SS; Hartung HP Lancet Neurol; 2004 Jun; 3(6):369-71. PubMed ID: 15157852 [TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879 [TBL] [Abstract][Full Text] [Related]
19. Statins: much more than just a lipid-lowering therapy. Raja SG; Dreyfus GD Indian Heart J; 2004; 56(3):204-9. PubMed ID: 15584561 [No Abstract] [Full Text] [Related]
20. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment. Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P; J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]